| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/20/2003 | WO2003014732A1 Apparatuses and methods for creating and testing pre-formulations and systems for same |
| 02/20/2003 | WO2003014731A2 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 02/20/2003 | WO2003014730A2 Method and apparatus for testing flexibility of woven wire-cloth |
| 02/20/2003 | WO2003014729A1 A method and apparatus for detecting extraneous matter in a fluid |
| 02/20/2003 | WO2003014728A1 Remedies for hepatitis c |
| 02/20/2003 | WO2003014727A1 Remedies for heart diseases |
| 02/20/2003 | WO2003014726A1 A lateral flow plasma separation device |
| 02/20/2003 | WO2003014724A1 A novel cancer marker and uses therefor in the diagnosis of cancer |
| 02/20/2003 | WO2003014708A1 Identification of particles in fluid |
| 02/20/2003 | WO2003014703A2 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 02/20/2003 | WO2003014701A2 Potentiometric probe compounds |
| 02/20/2003 | WO2003014699A2 Compositions and methods for detecting and quantifying cox-2 activity by lipoamino acid metabolism |
| 02/20/2003 | WO2003014698A2 Biological assay detection method |
| 02/20/2003 | WO2003014697A2 Amplification of analyte detection with passivated enhancing surfaces having receptors |
| 02/20/2003 | WO2003014696A2 Methods of identifying functional analogs of peptide regulators of biological pathways |
| 02/20/2003 | WO2003014695A2 Biosensor and method for detecting macromolecular biopolymers by means of at least one unit for immobilizing macromolecular biopolymers |
| 02/20/2003 | WO2003014601A1 Encoder-equipped sealing device |
| 02/20/2003 | WO2003014401A1 Methods for the identification of inhibitors of ferredoxin nadp oxidoreductase expression or activity in plants |
| 02/20/2003 | WO2003014395A1 Method of examining bronchial asthma |
| 02/20/2003 | WO2003014394A1 Method of evaluating biocompatibility |
| 02/20/2003 | WO2003014393A1 METHOD OF DETECTING, IDENTIFYING AND COUNTING ENTERITIS VIBRIO USING GENE (rpoD) SEQUENCES ENCODING RNA POLYMERASE σ70 FACTOR |
| 02/20/2003 | WO2003014388A2 Method and nucleic acids for the analysis of colon cancer |
| 02/20/2003 | WO2003014386A2 Method for identifying macrocyclic polyketides |
| 02/20/2003 | WO2003014383A2 Phenotypic effects of ubiquinone deficiencies and methods of screening thereof |
| 02/20/2003 | WO2003014382A2 Device for analyzing nucleic acid |
| 02/20/2003 | WO2003014381A1 System for detecting protease |
| 02/20/2003 | WO2003014380A2 Microoroganisms and cells for diagnosis and therapy of tumors |
| 02/20/2003 | WO2003014379A2 Improved method and composition for determining resistance to an acetohydroxyacid synthase inhibitor |
| 02/20/2003 | WO2003014377A2 Competitive binding assay for identifying inhibitors of hcv polymerase |
| 02/20/2003 | WO2003014359A2 A fusion protein |
| 02/20/2003 | WO2003014343A1 Method for analyzing inhibition of ftsz polymerization using fluorescence assay technique |
| 02/20/2003 | WO2003014342A2 Identification of a dna variant associated with adult type hypolactasia |
| 02/20/2003 | WO2003014334A1 Cell culture method for obtaining prostate-like acini |
| 02/20/2003 | WO2003014329A2 Modulation of angiogenesis by a-beta peptides |
| 02/20/2003 | WO2003014328A2 Methods and compounds for disruption of cd40r/cd40l signaling in the treatment of alzheimer's disease |
| 02/20/2003 | WO2003014325A2 Protein design automation for protein libraries |
| 02/20/2003 | WO2003014323A2 Human smooth muscle myosin heavy chain |
| 02/20/2003 | WO2003014322A2 Proteins associated with cell growth, differentiation, and death |
| 02/20/2003 | WO2003014321A2 Compositions and methods for modulation of darpp-32 phosphorylation |
| 02/20/2003 | WO2003014308A2 Cysteine mutants and methods for detecting ligand binding to biological molecules |
| 02/20/2003 | WO2003014303A2 Molecular interactions in cells |
| 02/20/2003 | WO2003014302A2 Detection of differential expression of protein using gel-free proteomics |
| 02/20/2003 | WO2003014301A2 Hprp4s as modifiers of the p53 pathway and methods of use |
| 02/20/2003 | WO2003014300A2 TRPS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 02/20/2003 | WO2003014299A2 SPHKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 02/20/2003 | WO2003014298A2 Full-length prostate selective polynucleotides and polypeptides |
| 02/20/2003 | WO2003014294A2 Tacis and br3 polypeptides and uses thereof |
| 02/20/2003 | WO2003014291A1 Device and methods for detecting the response of a plurality of cells to at least one analyte of interest |
| 02/20/2003 | WO2003014255A1 Fluorescent diketopyrrolopyrrole analogues |
| 02/20/2003 | WO2003014159A1 Methods of screening based on the egf receptor crystal structure |
| 02/20/2003 | WO2003014153A2 Cellular virus receptors and methods of use. |
| 02/20/2003 | WO2003014151A2 Human secreted proteins, their encoding polynucleotides, and uses thereof |
| 02/20/2003 | WO2003014145A2 Peptides that bind to atherosclerotic lesions |
| 02/20/2003 | WO2003014144A2 Molecule |
| 02/20/2003 | WO2003014142A2 Phosphorylated histone h2b as an apoptosis marker |
| 02/20/2003 | WO2003014138A2 Method for immobilizing compounds by means of nitron formation and arrangement for immobilizing compounds |
| 02/20/2003 | WO2003014077A2 Crystal forms and mutants of rank ligand |
| 02/20/2003 | WO2003014037A1 Method and device for detecting imminent surface adhesion between a glass body to be formed and a form tool |
| 02/20/2003 | WO2003013603A1 Modulators of p-selectin glycoprotein ligand 1 |
| 02/20/2003 | WO2003013602A1 Inhibitors of her3 activity |
| 02/20/2003 | WO2003013590A1 Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer |
| 02/20/2003 | WO2003013585A1 Mifaxin agonists and antagonists for use in the treatment of metabolic |
| 02/20/2003 | WO2003013584A1 Xafinix agonists and antagonists for use in the treatment of metabolic disorders |
| 02/20/2003 | WO2003013583A1 Faxigen agonists and antagonists in the treatment of metabolic disorders |
| 02/20/2003 | WO2003013582A1 Genoxit agonists and antagonists for use in the treatment of metabolic disorders |
| 02/20/2003 | WO2003013581A1 Agonists and antagonists of genceptin for the treatment of metabolic disorders |
| 02/20/2003 | WO2003013580A1 Tr xidatin agonists and antagonists treatment of metabolic disorders |
| 02/20/2003 | WO2003013579A1 Lypergix agonists and antagonists for use in the treatment of metabolic disorders |
| 02/20/2003 | WO2003013578A1 Omoxin agonists and antagonists for use in the treatment of metabolic disorders |
| 02/20/2003 | WO2003013551A1 G protein-coupled receptor assay |
| 02/20/2003 | WO2003013434A2 Methods and compositions for treating diseases associated with excesses in ace |
| 02/20/2003 | WO2003013431A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 02/20/2003 | WO2003013425A2 In vitro assays for inhibitors of hiv capsid conformational changes and for hiv capsid formation |
| 02/20/2003 | WO2003013423A2 Antithrombotic agent |
| 02/20/2003 | WO2003013422A2 Methods for the treatment and prognosis of leukemia and other cancer types |
| 02/20/2003 | WO2003013234A2 Method for the in vivo screening of the biological activity of an acetylcholinesterase inhibitor compound on one or more cellular targets other than acetylcholinesterase |
| 02/20/2003 | WO2002101084A3 Scintillation proximity assays for aminoglycoside binding molecules |
| 02/20/2003 | WO2002099431A3 Use of cytosolic nadp-dependent isocitrate dehydrogenase in bodily fluids and stools for identifying a malign illness and a test kit therefor |
| 02/20/2003 | WO2002099386A3 Microcalorimetric detection of analytes and binding events |
| 02/20/2003 | WO2002099381A3 A single-cell biosensor for the measurement of gpcr ligands in a test sample |
| 02/20/2003 | WO2002099138A3 HS2STs AS MODIFIERS OF THE P53 PATHWAY AND METHODS OF USE |
| 02/20/2003 | WO2002096267A3 Noninvasive intraductal fluid diagnostic screen |
| 02/20/2003 | WO2002096262A3 Non-alloying core shell nanoparticles |
| 02/20/2003 | WO2002095394A3 Method for analyzing a biological sample |
| 02/20/2003 | WO2002092769A3 System for discovery of agents that block yersinia pestis and pseudomonas aeruginosa dna replication |
| 02/20/2003 | WO2002090924A3 Mutation induced optimization of receptor signal to noise ratio |
| 02/20/2003 | WO2002086085A3 Human timp-1 antibodies |
| 02/20/2003 | WO2002079387A3 Modular molecular clasps and uses thereof |
| 02/20/2003 | WO2002079085A3 Surface modification of porous silicon |
| 02/20/2003 | WO2002077264A3 Arrayed transfection method and uses related thereto |
| 02/20/2003 | WO2002076437A3 Methods for treating neurodegenerative diseases including alzheimer's |
| 02/20/2003 | WO2002074043A3 Device for the examination of fluids |
| 02/20/2003 | WO2002073158A3 Conjugate probes and optical detection of analytes |
| 02/20/2003 | WO2002072871A3 Method for association of genomic and proteomic pathways associated with physiological or pathophysiological processes |
| 02/20/2003 | WO2002072866A3 Method for quantitative measurement of gene expression for identifying individuals at risk for bronchogenic carcinoma |
| 02/20/2003 | WO2002072588A3 Photo-induced electron transfer fluorescent sensor molecules |
| 02/20/2003 | WO2002068645A8 Compositions and methods relating to breast specific genes and proteins |
| 02/20/2003 | WO2002068605A3 Non-oligomerizing tandem fluorescent proteins |
| 02/20/2003 | WO2002067766A3 Methods and material for evaluating cardiovascular conditions |
| 02/20/2003 | WO2002065092A3 Devices and methods for high throughput patch clamp assays |